共 183 条
- [11] Zhao J(2020)IL-18 and infections: is there a role for targeted therapies? J Cell Physiol 236 1638-1826
- [12] Hu Y(2021)Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 Nat Rev Immunol 21 319-e331
- [13] Zheng Z(2020)Remdesivir for the treatment of Covid-19 - final report N Engl J Med 383 1813-2418
- [14] Peng F(2020)Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study Lancet Rheumatol 2 e325-40
- [15] Xu B(2020)Observational study of hydroxychloroquine in hospitalized patients with Covid-19 N Engl J Med 382 2411-2344
- [16] Zhao J(2020)Effect of tocilizumab vs. usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial JAMA Intern Med 181 32-31
- [17] Liu H(2020)Efficacy of tocilizumab in patients hospitalized with Covid-19 N Engl J Med 383 2333-276
- [18] Peng J(2020)Effect of tocilizumab vs. standard care on clinical worsening in patients hospitalized With COVID-19 pneumonia: a randomized clinical trial JAMA Intern Med 181 24-41
- [19] Ruan Q(2020)Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial Lancet Respir Med 8 267-267
- [20] Yang K(1976)Prediction of creatinine clearance from serum creatinine Nephron 16 31-3330